Christopher Niyibizi
All publications ( 8 )
Liao X. Li F. Wang X. Yanoso J. Niyibizi C.
Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice.
2008 Apr.
Stem Cells Dev
. 17(2):303-14.
Li F. Wang X. Niyibizi C.
Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
2007 Dec.
Stem Cells
. 25(12):3183-93.
Wang X. Li F. Niyibizi C.
Progenitors Systemically Transplanted into Neonatal Mice Localize to Areas of Active Bone Formation in vivo: Implications of Cell Therapy for Skeletal Diseases.
2006 May 4.
Stem Cells
..
Niyibizi C. Wang S. Mi Z. Robbins PD.
The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells.
2004 Jun.
Mol Ther
. 9(6):955-63.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Niyibizi C. Wang S. Mi Z. Robbins PD.
Gene therapy approaches for osteogenesis imperfecta.
2004 Feb.
Gene Ther
. 11(4):408-16.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Adachi N. Sato K. Usas A. Fu FH. Ochi M. Han CW. Niyibizi C. Huard J.
Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects.
2002 Sep.
J Rheumatol
. 29(9):1920-30.
Niyibizi C. Smith P. Mi Z. Phillips CL. Robbins P.
Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
2001 Jun 26-Jul 25.
J Cell Biochem
. 83(1):84-91.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute for Dental and Craniofacial Research
Oyama M. Tatlock A. Fukuta S. Kavalkovich K. Nishimura K. Johnstone B. Robbins PD. Evans CH. Niyibizi C.
Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
1999 Mar.
Gene Ther
. 6(3):321-9.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Public Health Service